Legal status in the United States

Is Tesamorelin legal?

Read at FDA, DEA and WADAPublished by PepVault

Tesamorelin is FDA-approved (Egrifta, first in 2010), is not a federally controlled substance, and is banned in sport (WADA names it under S2.2.4), as of November 18, 2026.

Tesamorelin at a glance

CheckStatus, read Nov 18, 2026
FDA approvalApproved (Egrifta, 2010)
CompoundingA biologic; FDA: not eligible for 503A or 503B
DEA scheduleNot controlled
Sport (WADA)Banned, named (S2.2.4)

FDA approval

Tesamorelin is FDA-approved as Egrifta, first in 2010, for one use: belly fat in adults with HIV and lipodystrophy.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Drugs@FDA lists tesamorelin as a biologic (BLA 022505, Egrifta), and FDA writes that biological products “are not eligible for the exemptions for compounded drugs under sections 503A and 503B”.

The source: “Biological products are not eligible for the exemptions for compounded drugs under sections 503A and 503B of the FD&C Act.”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

WADA bans tesamorelin at all times, in and out of competition: the 2026 list names it under S2.2.4, growth hormone releasing factors.

The source: “growth hormone-releasing hormone (GHRH) and its analogues (e.g. CJC-1293, CJC-1295, sermorelin and tesamorelin)”

What this means and doesn’t

This page reports what the agencies’ own pages said about Tesamorelin in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Tesamorelin FDA approved?

    Tesamorelin is FDA-approved as Egrifta, first in 2010, for one use: belly fat in adults with HIV and lipodystrophy.

  • Is Tesamorelin a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Tesamorelin banned in sport?

    WADA bans tesamorelin at all times, in and out of competition: the 2026 list names it under S2.2.4, growth hormone releasing factors.

  • What does FDA say about compounding Tesamorelin?

    Drugs@FDA lists tesamorelin as a biologic (BLA 022505, Egrifta), and FDA writes that biological products “are not eligible for the exemptions for compounded drugs under sections 503A and 503B”.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo